- Home
- BVS vs JBGS Comparison
BVS vs JBGS Comparison
Compare BVS & JBGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BVS | JBGS |
|---|---|---|
| Founded | 2011 | 2016 |
| Country | United States | United States |
| Employees | 950 | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 910.2M | 823.7M |
| IPO Year | 2016 | 2017 |
Fundamental Metrics
Financial Performance| Metric | BVS | JBGS |
|---|---|---|
| Price | $13.38 | $11.92 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 5 | 3 |
| Target Price | ★ $17.60 | $12.00 |
| AVG Volume (30 Days) | 371.8K | ★ 785.4K |
| Earning Date | 11-02-2026 | 11-10-2026 |
| Dividend Yield | N/A | ★ 5.83% |
| EPS Growth | ★ 163.46 | N/A |
| EPS | ★ 0.52 | N/A |
| Revenue | ★ $568,087,000.00 | $498,598,000.00 |
| Revenue This Year | $6.46 | N/A |
| Revenue Next Year | $6.74 | $2.61 |
| P/E Ratio | $28.56 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.47 | $9.93 |
| 52 Week High | $15.89 | $19.13 |
Technical Indicators
Market Signals| Indicator | BVS | JBGS |
|---|---|---|
| Relative Strength Index (RSI) | 46.10 | 62.89 |
| Support Level | $13.44 | $10.83 |
| Resistance Level | $14.33 | $12.77 |
| Average True Range (ATR) | 0.55 | 0.35 |
| MACD | 0.03 | 0.13 |
| Stochastic Oscillator | 19.26 | 85.66 |
Price Performance
Historical ComparisonAbout BVS Bioventus Inc.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
About JBGS JBG SMITH Properties
JBG SMITH Properties is a real estate investment trust based in the United States. It owns, operates, invests in, and develops real estate assets concentrated in amenity-rich, metro-served submarkets in and around Washington, DC. In addition, the company also provides fee-based real estate services to legacy funds through its third-party real estate services business. The operating segments of the company are commercial, multifamily, and third-party real estate services. It generates maximum revenue from the commercial segment.